Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer · 1977 · 8.4K citations · Full text

Public Health, Biostatistics, Clinical Medicine +13

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

J L Cordell, Brunangelo Falini, Wendy N. Erber et al. · Journal of Histochemistry & Cytochemistry · 1984 · 3.2K citations

Medicine, Biochemistry, Pathology +17

Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations

Life Sciences, Immunology, Oncology +12

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

Colin J. Barnstable · Cell · 1978 · 1.9K citations

Life Sciences, Genetics, Immunology +16